PETS PetMed Express, Inc. - Common Stock
NASDAQ · Retail · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026PETS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
PETS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
PetMed Express, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PETS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05Y ort. ≈9.3 | ≈9.3 | · | · | |
| F/S (TTM) | 0.25Y ort. ≈0.3 | ≈0.3 | 0.2 | Adil değer | |
| F/D (MRQ) | 1.35Y ort. ≈1.2 | ≈1.2 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.15Y ort. ≈-247.6 | ≈-247.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.25Y ort. ≈13.4 | ≈13.4 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 1.75Y ort. ≈2.2 | ≈2.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PETS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 27.9%5Y ort. ≈28.5% | ≈28.5% | 36.4% | Zayıf | |
| Faaliyet Kâr Marjı (TTM) | -18.2%5Y ort. ≈-8.5% | ≈-8.5% | -1.3% | Zayıf | |
| FAVÖK Marjı (TTM) | -12.7%5Y ort. ≈-5.8% | ≈-5.8% | -1.3% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -17.4%5Y ort. ≈-7.9% | ≈-7.9% | -2.0% | Zayıf | |
| Net Kâr Marjı (TTM) | -17.3%5Y ort. ≈-8.9% | ≈-8.9% | -2.0% | Zayıf | |
| ROA (TTM) | -33.7%5Y ort. ≈-19.4% | ≈-19.4% | -13.0% | Zayıf | |
| ROE (TTM) | -78.6%5Y ort. ≈-38.2% | ≈-38.2% | 12.9% | Zayıf | |
| ROIC | -202.5%5Y ort. ≈-77.2% | ≈-77.2% | -31.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PETS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.75Y ort. ≈1.1 | ≈1.1 | 1.3 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.45Y ort. ≈0.7 | ≈0.7 | 0.3 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PETS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -21.1%5Y ort. ≈-9.2% | ≈-9.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -10.2%5Y ort. ≈-6.5% | ≈-6.5% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -10.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PETS | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.65Y ort. ≈1.5 | ≈1.5 | 1.5 | Aynı seviyede | |
| Receivables Turnover (Alacak Devir Hızı) | 84.75Y ort. ≈92.6 | ≈92.6 | 84.7 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$947.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ağu 11, 2023 | $0,30 | USD | ≈9.4% |
| Haz 5, 2023 | $0,30 | USD | ≈8.2% |
| Şub 16, 2023 | $0,30 | USD | ≈6.1% |
| Kas 17, 2022 | $0,30 | USD | ≈6.3% |
| Ağu 11, 2022 | $0,30 | USD | ≈5.4% |
| May 19, 2022 | $0,30 | USD | ≈5.9% |
| Şub 4, 2022 | $0,30 | USD | ≈5.0% |
| Kas 5, 2021 | $0,30 | USD | ≈3.8% |
| Ağu 5, 2021 | $0,30 | USD | ≈4.0% |
| May 13, 2021 | $0,30 | USD | ≈4.1% |
| Oca 29, 2021 | $0,28 | USD | ≈2.9% |
| Kas 6, 2020 | $0,28 | USD | ≈3.7% |
| Tem 30, 2020 | $0,28 | USD | ≈3.5% |
| May 14, 2020 | $0,28 | USD | ≈3.4% |
| Oca 31, 2020 | $0,27 | USD | ≈4.3% |
| Kas 1, 2019 | $0,27 | USD | ≈4.7% |
| Ağu 1, 2019 | $0,27 | USD | ≈6.7% |
| May 16, 2019 | $0,27 | USD | ≈5.5% |
| Şub 1, 2019 | $0,27 | USD | ≈4.6% |
| Kas 2, 2018 | $0,27 | USD | ≈3.7% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2027 | Ağu 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 Aralık 2026 | Haz 2, 2026 | $-0.19 | $-0.18 | -3.5% |
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 Mart 2026 | $-0.19 | $-0.18 | -3.5% | |
| 31 Aralık 2025 | $-0.50 | $-0.06 | -717.0% | |
| 30 Haziran 2025 | $-1.65 | $-0.07 | -2210.9% | |
| 31 Mart 2025 | $-0.56 | $-0.05 | -1129.2% | |
| 31 Aralık 2024 | $-0.03 | $-0.01 | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | $4.12 | $4.57 | · | $6.78 | $6.97 | $6.45 | $6.51 | $5.62 | · | · | · | |
| Revenue / Share | $8.56 | $11.02 | $13.78 | $12.62 | $13.43 | $15.37 | · | · | $13.40 | · | · | · | |
| Cash Flow / Share | $-1.36 | $0.23 | $0.21 | $1.37 | $0.91 | $1.99 | $1.94 | $2.20 | $1.83 | · | · | · | |
| Cash / Share | $1.00 | $2.65 | $2.61 | · | $5.29 | $5.86 | $5.15 | $4.86 | $3.78 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 | $0.85 | $0.76 | $0.72 | · | |
| EPS (TTM) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.80 |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Gelir Tablosu
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,597,807 | 20,513,281 | · | 20,425,282 | 20,382,979 | 20,332,526 | · | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,938,817 | 20,941,505 | · | 20,425,282 | 20,780,455 | 20,332,526 | · | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Bilanço
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Nakit Akışı
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Kârlılık
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Verimlilik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Hisse Başına
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.06 | · | $1.53 | $2.05 | $2.47 | · | $4.66 | $4.67 | $4.54 | · | $4.73 | $4.75 | $4.92 | · | $6.34 | $6.55 | |
| Revenue / Share | $1.89 | · | $1.94 | $2.12 | $2.47 | · | $2.57 | $2.85 | $3.24 | · | $3.20 | $3.42 | $3.85 | · | $2.90 | $3.21 | |
| Cash Flow / Share | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.41 | · | · | · | $0.03 | · | · | · | |
| Cash / Share | $0.60 | · | $1.26 | $1.72 | $1.97 | · | $2.43 | $2.52 | $2.23 | · | $2.34 | $2.53 | $2.91 | · | $4.86 | $4.58 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | |
| EPS (TTM) | $-1.37 | · | $-3.12 | $-2.65 | $-2.13 | · | $0.02 | $-0.05 | $-0.13 | · | $-0.14 | $-0.05 | $0.06 | · | $0.44 | $0.66 |
Değerleme (TTM)
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $169M | · | $187M | $198M | $212M | · | $236M | $247M | $259M | · | $262M | $256M | $250M | · | $253M | $256M | |
| Net Income TTM | $-29M | · | $-65M | $-55M | $-44M | · | $357.0K | $-963.0K | $-3M | · | $-3M | $-849.0K | $1M | · | $9M | $13M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -1.4 | · | -1.0 | -0.9 | -1.6 | · | 241.0 | -73.6 | -31.2 | · | -54.0 | -205.0 | 229.8 | · | 40.2 | 29.6 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.2 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| Dividend Yield | 0.05% | · | 0.04% | 0.05% | 0.11% | · | 0.19% | 0.27% | 7.8% | · | 11.8% | 11.5% | 8.5% | · | 6.6% | 5.9% | |
| Earnings Yield | -71.4% | · | -97.5% | -105.6% | -64.2% | · | 0.41% | -1.4% | -3.2% | · | -1.8% | -0.49% | 0.44% | · | 2.5% | 3.4% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · | |
| Annual Payout | $20.0K | · | $29.0K | $29.0K | $78.0K | · | $194.0K | $208.0K | $6M | · | $19M | $25M | $25M | · | $24M | $24M |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Gelir | $179M | $227M | $274M | $248M | · |
| Brüt Kâr Marjı % | 28.1% | 30.5% | 28.0% | 27.6% | · |
| Faaliyet Kâr Marjı % | -32.8% | -0.67% | -2.9% | 2.4% | · |
| Net Gelir | $-57M | $-6M | $-7M | $5M | · |
| Seyreltilmiş Hisse Başı Kâr | $-2.74 | $-0.30 | $-0.37 | $0.25 | · |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 0.8 | 1.3 | 1.3 | · | · |
| Cari Oran | 0.4 | 0.9 | 0.8 | · | · |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-33M | $-395.0K | $-194.0K | $23M | · |
Kurumsal Sahipler (13F) 53 dosya · $11.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 10 (0 önceki Ç'ye göre) | 8 (-2 önceki Ç'ye göre) | 9 (-1 önceki Ç'ye göre) | 18 (+2 önceki Ç'ye göre) | -1.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.084.028 | 963.759 | 26,00% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $2.171.962 | 1.131.230 | 18,31% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.588.602 | 827.397 | 13,39% | Hisse senetleri |
| BlackRock, Inc. | $1.091.050 | 568.255 | 9,20% | Hisse senetleri |
| FEDERATED HERMES, INC. | $407.367 | 212.170 | 3,43% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $391.947 | 204.075 | 3,30% | Hisse senetleri |
| STEEL PARTNERS HOLDINGS L.P. | $371.835 | 193.664 | 3,13% | Hisse senetleri |
| UBS Group AG | $265.594 | 138.330 | 2,24% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232.412 | 121.048 | 1,96% | Hisse senetleri |
| Rangeley Capital, LLC | $232.320 | 121.000 | 1,96% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $212.124 | 110.481 | 1,79% | Hisse senetleri |
| STATE STREET CORP | $201.932 | 105.173 | 1,70% | Hisse senetleri |
| Formidable Asset Management, LLC | $195.056 | 85.551 | 1,64% | Hisse senetleri |
| Empowered Funds, LLC | $158.108 | 82.348 | 1,33% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $156.301 | 81.407 | 1,32% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152.646 | 79.503 | 1,29% | Hisse senetleri |
| CITADEL ADVISORS LLC | $142.324 | 74.127 | 1,20% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $115.811 | 60.353 | 0,98% | Hisse senetleri |
| UMB Bank, n.a. | $115.200 | 60.000 | 0,97% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91.647 | 47.733 | 0,77% | Hisse senetleri |
| NORTHERN TRUST CORP | $81.893 | 42.653 | 0,69% | Hisse senetleri |
| XTX Topco Ltd | $80.511 | 41.933 | 0,68% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $75.300 | 30.000 | 0,63% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $47.702 | 24.845 | 0,40% | Hisse senetleri |
| IMC-Chicago, LLC | $44.014 | 22.924 | 0,37% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $29.568 | 15.400 | 0,25% | Alım opsiyonu |
| Jain Global LLC | $26.148 | 13.619 | 0,22% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $24.712 | 12.871 | 0,21% | Hisse senetleri |
| MORGAN STANLEY | $22.282 | 11.604 | 0,19% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $17.637 | 9.186 | 0,15% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $15.590 | 8.120 | 0,13% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $6.772 | 3.527 | 0,06% | Hisse senetleri |
| SBI Securities Co., Ltd. | $2.148 | 1.119 | 0,02% | Hisse senetleri |
| Bank & Trust Co | $2.054 | 901 | 0,02% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $1.037 | 540 | 0,01% | Hisse senetleri |
| Accredited Wealth Management, LLC | $1.004 | 5.636 | 0,01% | Hisse senetleri |
| Allworth Financial LP | $949 | 494 | 0,01% | Hisse senetleri |
| MCF Advisors LLC | $768 | 400 | 0,01% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0,01% | Hisse senetleri |
| Ascentis Independent Advisors | $683 | 356 | 0,01% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0,00% | Hisse senetleri |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0,00% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0,00% | Hisse senetleri |
| Farther Finance Advisors, LLC | $290 | 151 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129.933 | 0,00% | Hisse senetleri |
| FMR LLC | $115 | 60 | 0,00% | Hisse senetleri |
| Elevated Capital Advisors, LLC | $96 | 50 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0,00% | Hisse senetleri |
| CITIGROUP INC | $17 | 9 | 0,00% | Hisse senetleri |
| CoreCap Advisors, LLC | $8 | 4 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 başvurular | 29 Haziran 2026 | 12,07% | Değişiklik | Pasif yatırım | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | 11 Şubat 2026 | 1,83% | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 29 içeriden öğrenenler · 8 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jeffrey Allen Willard | CEO and President | 28 Eylül 2026 A | 250.000 | 0 | 0 | $0 |
| Leslie C.G. Campbell | Interim CEO and President | 11 Ağustos 2026 A | 145.000 | 0 | 0 | $0 |
| Sandra Yvette Campos | CEO & President | 30 Nisan 2025 S | 578.524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | 27 Ocak 2021 S | 337.800 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | 26 Haziran 2026 A | 102.500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | 27 Eylül 2024 A | 250.000 | 0 | 0 | $0 |
| Christine Chambers | CFO | 31 Mayıs 2024 D | 65.146 | 0 | 0 | $0 |
| Bruce S Rosenbloom | Chief Financial Officer | 30 Temmuz 2021 A | 45.450 | 0 | 0 | $0 |
| Tamar Elkeles | Yönetim kurulu üyesi | 17 Eylül 2026 A | 49.923 | 0 | 0 | $0 |
| Peter Batushansky | Yönetim kurulu üyesi | 11 Ağustos 2026 A | 91.928 | 0 | 0 | $0 |
| Justin L. Mennen | Yönetim kurulu üyesi | 11 Ağustos 2026 A | 98.274 | 0 | 0 | $0 |
| Gian Fulgoni | Yönetim kurulu üyesi | 21 Ocak 2026 D | 132.299 | 0 | 0 | $0 |
| Leah Solivan | Yönetim kurulu üyesi | 30 Ekim 2025 A | 42.289 | 0 | 0 | $0 |
| Diana G Purcel | Yönetim kurulu üyesi | 08 Ağustos 2024 A | 24.375 | 0 | 0 | $0 |
| Jodi Watson | Yönetim kurulu üyesi | 28 Temmuz 2022 A | 18.880 | 0 | 0 | $0 |
| Peter Cobb | Yönetim kurulu üyesi | 28 Temmuz 2022 A | 15.000 | 0 | 0 | $0 |
| Ronald J Korn | Yönetim kurulu üyesi | 30 Temmuz 2021 A | 90.833 | 0 | 0 | $0 |
| Frank J Formica | Yönetim kurulu üyesi | 29 Ocak 2021 S | 55.000 | 0 | 0 | $0 |
| Robert C Schweitzer | Yönetim kurulu üyesi | 28 Ağustos 2020 S | 95.834 | 0 | 0 | $0 |
| Marc Puleo MD | Yönetim kurulu üyesi | 16 Ağustos 2005 J | 913.286 | 0 | 0 | $0 |
| SilverCape Investments Limited | 10% sahip | 13 Ağustos 2025 P | 2.579.696 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | 10% sahip | 04 Ağustos 2006 S | 2.284.000 | 0 | 0 | $0 |
| James Lacamp | · | 11 Ağustos 2026 A | 90.421 | 0 | 0 | $0 |
| Jacqueline Paula Smith | · | 15 Ocak 2025 A | 28.099 | 0 | 0 | $0 |
| Mathew N Hulett | · | 29 Nisan 2024 D | 103.850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | · | 11 Aralık 2023 A | 42.000 | 0 | 0 | $0 |
| Daniel Job Pingree | · | 17 Mayıs 2023 A | 22.000 | 0 | 0 | $0 |
| CRESLIN LTD | · | 04 Ağustos 2006 S | 2.284.000 | 0 | 0 | $0 |
| Guven Kivilcim | · | 22 Ocak 2004 S | 1.310.300 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 20 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| EWUS · iShares Trust | 0,25% | 37.222 SH | 11 Eylül 2026 | Günlük |
| ISVL · iShares Trust | 0,17% | 202.554 SH | 11 Eylül 2026 | Günlük |
| ISCF · iShares Trust | 0,09% | 216.018 SH | 11 Eylül 2026 | Günlük |
| IEUS · iShares Trust | 0,07% | 45.419 SH | 11 Eylül 2026 | Günlük |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,05% | 58.613 SH | 02 Ekim 2026 | Günlük |
| SCZ · iShares Trust | 0,03% | 1.496.647 SH | 11 Eylül 2026 | Günlük |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 1.566.925 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 26.193 SH | 11 Eylül 2026 | Günlük |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 1.056.528 SH | 19 Ağustos 2026 | Günlük |
| IEUR · iShares Trust | 0,01% | 291.699 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,01% | 51.213 SH | 11 Eylül 2026 | Günlük |
| IEFA · iShares Trust | 0,00% | 3.372.753 SH | 11 Eylül 2026 | Günlük |
| IDEV · iShares Trust | 0,00% | 546.389 SH | 11 Eylül 2026 | Günlük |
| IXUS · iShares Trust | 0,00% | 684.652 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 211.088 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 602.795 SH | 19 Ağustos 2026 | Günlük |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 6.557.275 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 341.189 SH | 19 Ağustos 2026 | Günlük |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 4.366.658 SH | 19 Ağustos 2026 | Günlük |
| VSGX · VANGUARD WORLD FUND | 0,00% | 78.854 SH | 19 Ağustos 2026 | Günlük |
PETS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
1 analist · 2026-10-01Ortalama hedef $1.40 +2,9%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PETS | $49M | -0.8 | -21.1% | -32.0% | -100.4% | 28.1% |
| RENT | · | 3.7 | 7.7% | 6.9% | -16.9% | · |
| GROV | $46M | -3.2 | -14.6% | -6.7% | 75.6% | 53.7% |
| SPWH | $52M | -1.1 | 0.96% | -4.1% | -25.2% | 30.9% |
| LESL | $46M | -0.2 | -6.6% | -19.1% | 70.0% | 35.4% |
| ULTA | $27.83B | 24.6 | 9.7% | 9.3% | 42.7% | 39.1% |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.